IL10 and inflammatory bowel disease: Kotlarz and colleagues identified ‘loss-of-function’ mutations in either IL10 or IL10R in  ̃25% of patients with severe infantile IBD (refractory colitis and perianal disease within the first 3 months of life) [114].